School of Women's and Children's Health, UNSW Medicine and Health, UNSW Sydney, Australia; St George and Sutherland Clinical School, UNSW Medicine and Health, UNSW Sydney, Australia.
St George and Sutherland Clinical School, UNSW Medicine and Health, UNSW Sydney, Australia; Department of Women and Children's Health, St George Hospital, Sydney, Australia.
Pregnancy Hypertens. 2022 Mar;27:29-34. doi: 10.1016/j.preghy.2021.10.004. Epub 2021 Oct 30.
Hypertensive disorders of pregnancy are associated with subsequent increased risk of cardiometabolic disease. Adverse cardiometabolic measures are noted soon after hypertensive versus normotensive pregnancy (NP); to what degree these persist into a subsequent pregnancy (SP) is unknown. This study aimed to assess women's physiology early in SP after hypertensive pregnancy (HP: preeclampsia or gestational hypertension) or NP and compare SP to 6 months postpartum findings from the index pregnancy.
Prospective sub-study of the P4 (Postpartum, Physiology, Psychology and Paediatric) observational cohort. Measurements six months after NP versus HP, and the SP at 11-13 weeks gestation.
Blood pressure (BP), blood and urine tests (urine ACR, HOMA-IR, LDL cholesterol), body composition, and contribution of maternal characteristics and inter-pregnancy factors to BP and body fat (FM%) in SP.
49 women (34 NP, 15 HP). In the SP, post-HP women had higher BP (112/70 mmHg HP vs 102/64 mmHg NP; p < .001), with no significant drop from six months postpartum to early SP. On regression analysis, systolic and diastolic BP at 6-months were the major predictors for SP systolic (p < 0.001) and diastolic (p = 0.009) BP respectively in the SP. Longer interpregnancy interval and increased FM% 6-months postpartum were associated with higher SP FM% (p < 0.001).
BP and body fat six months postpartum were similar early in the SP for HP group, and postpartum BP and FM% were major predictors of their corresponding SP measurements. Postpartum/inter-pregnancy intervention programs to improve these cardiometabolic risk markers might help improve women's long-term health and require investigation.
妊娠高血压疾病与随后发生心血管代谢疾病的风险增加有关。与正常血压妊娠(NP)相比,高血压妊娠(HP)后不久就会出现心血管代谢不良指标;这些指标在随后的妊娠(SP)中持续存在到什么程度尚不清楚。本研究旨在评估 HP 或 NP 后 SP 早期妇女的生理状况,并将 SP 与指数妊娠产后 6 个月的发现进行比较。
前瞻性 P4(产后、生理学、心理学和儿科)观察队列的子研究。测量 NP 后 6 个月与 HP 后,以及 SP 在 11-13 周妊娠时的测量。
血压(BP)、血液和尿液检查(尿液 ACR、HOMA-IR、LDL 胆固醇)、身体成分以及母婴特征和两次妊娠之间因素对 SP 中 BP 和体脂肪(FM%)的影响。
49 名女性(34 名 NP,15 名 HP)。在 SP 中,产后 HP 女性的 BP 更高(112/70mmHg HP 与 102/64mmHg NP;p<0.001),从产后 6 个月到早期 SP 没有明显下降。在回归分析中,6 个月时的收缩压和舒张压是 SP 收缩压(p<0.001)和舒张压(p=0.009)的主要预测因子。产后间隔时间延长和产后 6 个月时 FM%增加与 SP 中更高的 FM%相关(p<0.001)。
HP 组产后 6 个月时 SP 早期的 BP 和体脂肪相似,产后 BP 和 FM%是相应 SP 测量的主要预测因子。改善这些心血管代谢风险标志物的产后/两次妊娠干预方案可能有助于改善女性的长期健康,需要进一步研究。